Acamprosate 333mg gastro-resistant tablets
Aciclovir 800mg tablets
Alverine 60mg capsules
Amiloride 5mg tablets
Bimatoprost 100micrograms/ml eye drops
Bumetanide 1mg tablets
Carbocisteine 250mg/5ml oral solution
Carvedilol 6.25mg tablets
Clarithromycin 125mg/5ml oral suspension
Clonazepam 2mg tablets
Clonazepam 500microgram tablets
Clotrimazole 500mg pessaries
Co-careldopa 25mg/100mg tablets
Docusate 50mg/5ml oral solution sugar free
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free
Eplerenone 25mg tablets
Febuxostat 80mg tablets
Flecainide 100mg tablets
Hydrocortisone 1% cream
Hydroxychloroquine 200mg tablets
Lamotrigine 100mg tablets
Lansoprazole 30mg orodispersible tablets
Latanoprost 50micrograms/ml eye drops
Lofepramine 70mg tablets
Mercaptopurine 50mg tablets
Metformin 1g modified-release tablets
Methylphenidate 10mg tablets
Moxonidine 200microgram tablets
Mycophenolate mofetil 500mg tablets
Orlistat 120mg capsules
Pregabalin 300mg capsules
Pregabalin 75mg capsules
Risperidone 1mg/ml oral solution sugar free
Rosuvastatin 10mg tablets
Rosuvastatin 20mg tablets
Rosuvastatin 40mg tablets
Rosuvastatin 5mg tablets
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops
For the full list of price concessions granted so far for July 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.